SOP for Evaluating Drug-Drug Interactions in Preclinical Models
SOP for Evaluating Drug-Drug Interactions in Preclinical Models Standard Operating Procedure (SOP) for Evaluating Drug-Drug Interactions in Preclinical Models 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedures for evaluating potential drug-drug interactions (DDIs) in preclinical models. Understanding DDIs is crucial to assess the safety, efficacy, and pharmacokinetic behavior…
Read More “SOP for Evaluating Drug-Drug Interactions in Preclinical Models” »